ScinoPharm Taiwan (Taiwan) Today
| 1789 Stock | TWD 22.80 0.10 0.44% |
PerformanceModest
| Odds Of DistressLow
|
ScinoPharm Taiwan is selling for under 22.80 as of the 17th of March 2025; that is 0.44 percent increase since the beginning of the trading day. The stock's lowest day price was 22.65. ScinoPharm Taiwan has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells CGMP active pharmaceutical ingredients to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. ScinoPharm Taiwan, Ltd. The company has 790.74 M outstanding shares. More on ScinoPharm Taiwan
Moving against ScinoPharm Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ScinoPharm Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ScinoPharm Taiwan's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ScinoPharm Taiwan or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | ChihHsien Lo |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
ScinoPharm Taiwan (1789) is traded on Taiwan Stock Exchange in Taiwan and employs 47 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 20.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ScinoPharm Taiwan's market, we take the total number of its shares issued and multiply it by ScinoPharm Taiwan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ScinoPharm Taiwan operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 790.74 M outstanding shares.
ScinoPharm Taiwan has accumulated about 4.72 B in cash with 509.82 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.97.
Check ScinoPharm Taiwan Probability Of Bankruptcy
Ownership AllocationScinoPharm Taiwan shows a total of 790.74 Million outstanding shares. ScinoPharm Taiwan maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check ScinoPharm Ownership Details
ScinoPharm Taiwan Risk Profiles
Although ScinoPharm Taiwan's alpha and beta are two of the key measurements used to evaluate ScinoPharm Taiwan's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8349 | |||
| Standard Deviation | 1.05 | |||
| Variance | 1.1 | |||
| Risk Adjusted Performance | (0.04) |
ScinoPharm Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ScinoPharm Taiwan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
ScinoPharm Taiwan Corporate Management
Elected by the shareholders, the ScinoPharm Taiwan's board of directors comprises two types of representatives: ScinoPharm Taiwan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ScinoPharm. The board's role is to monitor ScinoPharm Taiwan's management team and ensure that shareholders' interests are well served. ScinoPharm Taiwan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ScinoPharm Taiwan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shun Lin | Director Devel | Profile | |
| ChihHui Lin | Sr Off | Profile | |
| LiAn Lu | Deputy General Manager-Administrative Management Center | Profile | |
| Jason Chen | Director Admin | Profile | |
| LingHsiao Lien | VicePres Operations | Profile | |
| BS MS | VP Officer | Profile |
Additional Tools for ScinoPharm Stock Analysis
When running ScinoPharm Taiwan's price analysis, check to measure ScinoPharm Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScinoPharm Taiwan is operating at the current time. Most of ScinoPharm Taiwan's value examination focuses on studying past and present price action to predict the probability of ScinoPharm Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScinoPharm Taiwan's price. Additionally, you may evaluate how the addition of ScinoPharm Taiwan to your portfolios can decrease your overall portfolio volatility.